Home/Filings/4/0000899243-23-004061
4//SEC Filing

Barton Debora 4

Accession 0000899243-23-004061

CIK 0001783328other

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 5:14 PM ET

Size

5.4 KB

Accession

0000899243-23-004061

Insider Transaction Report

Form 4
Period: 2023-02-02
Barton Debora
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-02+50,00050,000 total
    Exercise: $1.81Exp: 2033-02-01Voting Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.

Issuer

TScan Therapeutics, Inc.

CIK 0001783328

Entity typeother

Related Parties

1
  • filerCIK 0001936730

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:14 PM ET
Size
5.4 KB